Carolyn Bertozzi | |
---|---|
Born | Carolyn Ruth Bertozzi October 10, 1966 Boston, Massachusetts, U.S. |
Education | Harvard University (BS) University of California, Berkeley (MS, PhD) |
Known for | Bioorthogonal chemistry |
Relatives | Andrea Bertozzi (sister) |
Awards | MacArthur Foundation Fellowship (1999) ACS Award in Pure Chemistry (2001) Lemelson-MIT Prize (2010) Heinrich Wieland Prize (2012) Wolf Prize (2022) Welch Award in Chemistry (2022) Nobel Prize in Chemistry (2022) |
Scientific career | |
Fields | Chemistry |
Institutions | Stanford University University of California, Berkeley Lawrence Berkeley National Laboratory University of California, San Francisco |
Thesis | Synthesis and biological activity of carbon-linked glycosides (1993) |
Doctoral advisor | Mark D. Bednarski |
Doctoral students | |
Influenced | Kristi Kiick |
Carolyn Ruth Bertozzi (born October 10, 1966) is an American chemist and Nobel laureate, known for her wide-ranging work spanning both chemistry and biology. She coined the term "bioorthogonal chemistry" [2] for chemical reactions compatible with living systems. Her recent efforts include synthesis of chemical tools to study cell surface sugars called glycans and how they impact diseases such as cancer, inflammation, and viral infections like COVID-19. [3] At Stanford University, she holds the Anne T. and Robert M. Bass Professorship in the School of Humanities and Sciences. [4] Bertozzi is also an Investigator at the Howard Hughes Medical Institute (HHMI) [5] and is the former Director of the Molecular Foundry, a nanoscience research center at Lawrence Berkeley National Laboratory. [6]
She received the MacArthur "genius" award at age 33. [7] In 2010, she was the first woman to receive the prestigious Lemelson-MIT Prize faculty award. She is a member of the National Academy of Sciences (2005), the Institute of Medicine (2011), and the National Academy of Inventors (2013). In 2014, it was announced that Bertozzi would lead ACS Central Science , the American Chemical Society's first peer-reviewed open access journal, which offers all content free to the public. [8] As an open lesbian in academia and science, Bertozzi has been a role model for students and colleagues. [9] [10]
Bertozzi was awarded the 2022 Nobel Prize in Chemistry, jointly with Morten P. Meldal and Karl Barry Sharpless, "for the development of click chemistry and bioorthogonal chemistry". [11]
Carolyn Bertozzi received her A.B. summa cum laude in chemistry from Harvard University, where she worked with Professor Joe Grabowski on the design and construction of a photoacoustic calorimeter. [12] While an undergraduate, she played in various bands. Her most notable one was Bored of Education, which included future Rage Against the Machine guitarist Tom Morello. [13] [14] After graduating from Harvard in 1988, she worked at Bell Labs with Chris Chidsey. [15]
Bertozzi completed her Ph.D. in chemistry at University of California, Berkeley in 1993 with Mark Bednarski, working on the chemical synthesis of oligosaccharide analogs. [16] While at Berkeley, she discovered that viruses can bind to sugars in the body. [17] The discovery led her to her current field of research, glycobiology. During Bertozzi's third year of graduate school, Bednarski was diagnosed with colon cancer, which resulted in him taking a leave of absence and changing his career path by enrolling in medical school. This left Bertozzi and the rest of the lab to complete their Ph.D. work with no direct supervision. [18]
After graduating from Berkeley with a Ph.D., Bertozzi was a postdoctoral fellow at University of California, San Francisco (UCSF) with Steven Rosen, where she studied the activity of endothelial oligosaccharides in promoting cell adhesion at inflammation sites. [19] [20] While working with Rosen at UCSF, Bertozzi was able to modify the protein and sugar molecules in the walls of living cells so that the cells accept foreign materials such as implants. [21]
Bertozzi joined the Berkeley faculty in 1996. [19] She has been an investigator with HHMI since 2000. [6] In 1999, while working with HHMI and at Berkeley, she founded the field of bioorthogonal chemistry and coined the term in 2003. [22] [23] [24] This new field and technique allows researchers to chemically modify molecules in living organisms and not interrupt the processes of the cell. [25] In 2015, Bertozzi moved to Stanford University to join the ChEM-H Institute. [26]
Bertozzi studies the glycobiology of underlying diseases such as cancer, inflammatory disorders such as arthritis, and infectious diseases such as tuberculosis. In particular, Bertozzi has advanced the understanding of cell surface oligosaccharides involved in cell recognition and inter-cellular communication. Bertozzi has applied the techniques of bioorthogonal chemistry to study glycocalyx, the sugars that surround the cell membrane. Her discoveries have advanced the field of biotherapeutics. [27] Her lab has also developed tools for research. One such development is creating chemical tools for studying glycans in living systems. [6] Her lab's development of nanotechnologies which probe biological systems lead to the development of a fast point-of-care tuberculosis test in 2018. [28] [29] In 2017, due to her lab's discovery of linking the sugars on the surface of cancer cells and their ability to avoid the immune system defenses, she was invited to speak at Stanford's TED talk, giving a talk entitled "What the sugar coating on your cells is trying to tell you". [30]
In addition to her academic work, Bertozzi works actively with biotechnology start-ups.
In the early 2000s, Bertozzi and Steve Rosen co-founded Thios Pharmaceuticals the first company to target sulfation pathways. [31]
In 2008, Bertozzi founded a startup of her own: Redwood Bioscience of Emeryville, California. [32] Redwood Bioscience is a biotechnology company that uses SMARTag, a site-specific protein modification technology that allows small drugs to attach to sites on the proteins and can be used to help fight cancers. [17] [33] Redwood Bioscience was acquired by Catalent Pharma Solutions in 2014. Bertozzi remains a part of the advisory board for the biologics sector of the company. [33]
In 2014, she co-founded Enable Biosciences which focuses on biotechnologies for at-home diagnoses for type 1 diabetes, HIV, and other diseases. [22] [34]
Bertozzi became a co-founder of Palleon Pharma of Waltham, Massachusetts, in 2015. [35] Palleon Pharma focuses on investigating glycoimmune checkpoint inhibitors as a potential treatment for cancer. [36]
In 2017, Bertozzi helped found InterVenn Biosciences, which uses mass spectrometry and artificial intelligence to enhance glycoproteomics for target and biomarker discovery, ovarian cancer diagnostics, and predicting the successes and failures of clinical trials. [22] [37]
She co-founded Grace Science Foundation in 2018. The foundation focuses on curing NGLY1 deficiency through developing therapeutics that are efficient and inexpensive. [38]
In 2019, she co-founded both OliLux Biosciences and Lycia Therapeutics. OliLux Biosciences develops new methods for tuberculosis detection. [22] [39] The founding of Lycia Therapeutics occurred when Bertozzi's group discovered lysosome-targeting chimeras (LYTACs). The new molecule class may be able to degrade some cardiovascular disease and cancer targets. [40] Lycia Therapeutics focuses on developing technology which utilizes lysosome-targeting chimeras (LYTACs). [22]
Dr. Bertozzi has also previously served on the research advisory board of several pharmaceutical companies including GlaxoSmithKline, and until recently Eli Lilly. [41]
Bertozzi has over 600 publications on Web of Science; listed below are the most cited:
Carolyn Bertozzi grew up in Lexington, Massachusetts. She is the daughter of the late Norma Bertozzi and William Bertozzi. She has two sisters, one of whom, Andrea Bertozzi, is on the mathematics faculty at UCLA. [75] Her father, William, was a physics professor at MIT. [76] [77] [78]
Bertozzi is a lesbian, and has been out since the late 1980s. [79]
Gertrude "Trudy"Belle Elion was an American biochemist and pharmacologist, who shared the 1988 Nobel Prize in Physiology or Medicine with George H. Hitchings and Sir James Black for their use of innovative methods of rational drug design for the development of new drugs. This new method focused on understanding the target of the drug rather than simply using trial-and-error. Her work led to the creation of the anti-retroviral drug AZT, which was the first drug widely used against AIDS. Her well known works also include the development of the first immunosuppressive drug, azathioprine, used to fight rejection in organ transplants, and the first successful antiviral drug, acyclovir (ACV), used in the treatment of herpes infection.
Robert Samuel Langer, Jr. FREng is an American chemical engineer, scientist, entrepreneur, inventor and one of the twelve Institute Professors at the Massachusetts Institute of Technology.
Roger Yonchien Tsien was an American biochemist. He was a professor of chemistry and biochemistry at the University of California, San Diego and was awarded the Nobel Prize in Chemistry for his discovery and development of the green fluorescent protein, in collaboration with organic chemist Osamu Shimomura and neurobiologist Martin Chalfie. Tsien was also a pioneer of calcium imaging.
Lara K. Mahal is the Canada Excellence Research Chair in Glycomics at the University of Alberta in Edmonton, Alberta, Canada. She is also a Professor of Chemistry at the University of Alberta. She is notable both for her pioneering work establishing lectin microarrays as a new technology for glycomics, her work on miRNA regulation of glycosylation and her graduate work with Carolyn R. Bertozzi on unnatural carbohydrate incorporation. Work in her laboratory focuses on understanding the role of carbohydrates in human health using systems- and chemical biology-based approaches
JoAnne Stubbe is an American chemist best known for her work on ribonucleotide reductases, for which she was awarded the National Medal of Science in 2009. In 2017, she retired as a Professor of Chemistry and Biology at the Massachusetts Institute of Technology.
Xiaowei Zhuang is a Chinese-American biophysicist who is the David B. Arnold Jr. Professor of Science, Professor of Chemistry and Chemical Biology, and Professor of Physics at Harvard University, and an Investigator at the Howard Hughes Medical Institute. She is best known for her work in the development of Stochastic Optical Reconstruction Microscopy (STORM), a super-resolution fluorescence microscopy method, and the discoveries of novel cellular structures using STORM. She received a 2019 Breakthrough Prize in Life Sciences for developing super-resolution imaging techniques that get past the diffraction limits of traditional light microscopes, allowing scientists to visualize small structures within living cells. She was elected a Member of the American Philosophical Society in 2019 and was awarded a Vilcek Foundation Prize in Biomedical Science in 2020.
Laura Lee Kiessling is an American chemist and the Novartis Professor of Chemistry at the Massachusetts Institute of Technology. Kiessling's research focuses on elucidating and exploiting interactions on the cell surface, especially those mediated by proteins binding to carbohydrates. Multivalent protein-carbohydrate interactions play roles in cell-cell recognition and signal transduction. Understanding and manipulating these interactions provides tools to study biological processes and design therapeutic treatments. Kiessling's interdisciplinary research combines organic synthesis, polymer chemistry, structural biology, and molecular and cell biology.
Alanna Schepartz is an American professor and scientist. She is currently the T.Z. and Irmgard Chu Distinguished Chair in Chemistry at University of California, Berkeley. She was formerly the Sterling Professor of Chemistry at Yale University.
The term bioorthogonal chemistry refers to any chemical reaction that can occur inside of living systems without interfering with native biochemical processes. The term was coined by Carolyn R. Bertozzi in 2003. Since its introduction, the concept of the bioorthogonal reaction has enabled the study of biomolecules such as glycans, proteins, and lipids in real time in living systems without cellular toxicity. A number of chemical ligation strategies have been developed that fulfill the requirements of bioorthogonality, including the 1,3-dipolar cycloaddition between azides and cyclooctynes, between nitrones and cyclooctynes, oxime/hydrazone formation from aldehydes and ketones, the tetrazine ligation, the isocyanide-based click reaction, and most recently, the quadricyclane ligation.
Jennifer Anne Doudna is an American biochemist who has done pioneering work in CRISPR gene editing, and made other fundamental contributions in biochemistry and genetics. She received the 2020 Nobel Prize in Chemistry, with Emmanuelle Charpentier, "for the development of a method for genome editing." She is the Li Ka Shing Chancellor's Chair Professor in the Department of Chemistry and the Department of Molecular and Cell Biology at the University of California, Berkeley. She has been an investigator with the Howard Hughes Medical Institute since 1997.
Erin K. O'Shea Ph.D. is President of the Howard Hughes Medical Institute (HHMI). In 2013, she was named HHMI's Vice President and Chief Scientific Officer. Prior to that, she was a Professor of Molecular and Cellular Biology and Chemistry and Chemical Biology at Harvard University. In 2016, her appointment as future, and first woman, President of HHMI was announced. She has been a Howard Hughes Medical Institute (HHMI) investigator since 2000.
Zhenan Bao, is the K. K. Lee Professor of Chemical Engineering at Stanford University, with courtesy appointments in Chemistry and Material Science and Engineering. She has served as the Department Chair of Chemical Engineering from 2018-2022. She is known for her work on organic field-effect transistors and organic semiconductors, for applications including flexible electronics and electronic skin.
Paula Therese Hammond is a David H. Koch Professor in Engineering and the Head of the Department of Chemical Engineering at the Massachusetts Institute of Technology (MIT). She was the first woman and person of color appointed as head of the Chemical Engineering department. Her laboratory designs polymers and nanoparticles for drug delivery and energy-related applications including batteries and fuel cells.
Judith P. Klinman is an American chemist, biochemist, and molecular biologist known for her work on enzyme catalysis. She became the first female professor in the physical sciences at the University of California, Berkeley in 1978, where she is now Professor of the Graduate School and Chancellor's Professor. In 2012, she was awarded the National Medal of Science by President Barack Obama. She is a member of the National Academy of Sciences, American Academy of Arts and Sciences, American Association for the Advancement of Science, and the American Philosophical Society.
Ramesh Jasti is a professor of organic chemistry at the University of Oregon. He was the first person to synthesize the elusive cycloparaphenylene in 2008 during post doctoral work in the laboratory of Professor Carolyn Bertozzi. He started his laboratory at Boston University where he was the recipient of the NSF CAREER award. His early lab repeatedly broke the record for the synthesis of the smallest cycloparaphenylene known. In 2014, he moved his laboratory to the University of Oregon where he expanded his focus to apply the molecules he discovered in the areas of organic materials, mechanically interlocked molecules, and biology. He is the Associate Director of the Materials Science Institute at the University of Oregon.
Mireille Kamariza is a Burundian-born American bioscientist and Harvard Junior Fellow. Her research considers infectious diseases, the development of low cost point-of-care diagnostics and global health. In 2020 she was named as one of Chemical & Engineering News's Talented 12.
Celeste M. Nelson is a Professor of Chemical and Biological Engineering and the Director of the Program in Engineering Biology at Princeton University. She is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE) and was a finalist in the 2017 and 2018 Blavatnik Awards for Young Scientists.
Jessica R. Kramer is an American biomedical engineer working as an Assistant Professor of Bio-engineering and Adjunct Assistant Professor of Pharmaceutics and Pharmaceutical Chemistry at the University of Utah. Kramer’s research lab focuses on the synthesis and application of glycopolypeptides.
Ellen Sletten is an American chemist who is the John McTague Career Development Chair at University of California, Los Angeles. Her research considers the use of physical organic chemistry for diagnostics and medical therapies.
Jennifer Ann Prescher is an American chemist who is a professor of chemistry at the University of California, Irvine. Her research considers the development of bioorthogonal, bioluminescent tools for the noninvasive, real-time imaging of immunometabolism.
{{cite journal}}
: Missing or empty |title=
(help); Text "title"ONE ON ONE WITH CAROLYN BERTOZZI"" ignored (help)